9-133671557-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_001134707.2(SARDH):c.2304C>T(p.Ile768=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.465 in 1,605,978 control chromosomes in the GnomAD database, including 178,125 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.51 ( 19917 hom., cov: 30)
Exomes 𝑓: 0.46 ( 158208 hom. )
Consequence
SARDH
NM_001134707.2 synonymous
NM_001134707.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.993
Genes affected
SARDH (HGNC:10536): (sarcosine dehydrogenase) This gene encodes an enzyme localized to the mitochondrial matrix which catalyzes the oxidative demethylation of sarcosine. This enzyme is distinct from another mitochondrial matrix enzyme, dimethylglycine dehydrogenase, which catalyzes a reaction resulting in the formation of sarcosine. Mutations in this gene are associated with sarcosinemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 9-133671557-G-A is Benign according to our data. Variant chr9-133671557-G-A is described in ClinVar as [Benign]. Clinvar id is 3059243.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.993 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.722 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SARDH | NM_001134707.2 | c.2304C>T | p.Ile768= | synonymous_variant | 18/21 | ENST00000439388.6 | NP_001128179.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARDH | ENST00000439388.6 | c.2304C>T | p.Ile768= | synonymous_variant | 18/21 | 2 | NM_001134707.2 | ENSP00000403084 | P1 | |
SARDH | ENST00000371872.8 | c.2304C>T | p.Ile768= | synonymous_variant | 18/21 | 1 | ENSP00000360938 | P1 | ||
SARDH | ENST00000371868.5 | c.588C>T | p.Ile196= | synonymous_variant | 6/9 | 2 | ENSP00000360934 |
Frequencies
GnomAD3 genomes AF: 0.506 AC: 76688AN: 151488Hom.: 19909 Cov.: 30
GnomAD3 genomes
AF:
AC:
76688
AN:
151488
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.504 AC: 119866AN: 237862Hom.: 31688 AF XY: 0.491 AC XY: 63407AN XY: 129016
GnomAD3 exomes
AF:
AC:
119866
AN:
237862
Hom.:
AF XY:
AC XY:
63407
AN XY:
129016
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.461 AC: 669871AN: 1454372Hom.: 158208 Cov.: 51 AF XY: 0.459 AC XY: 332096AN XY: 722810
GnomAD4 exome
AF:
AC:
669871
AN:
1454372
Hom.:
Cov.:
51
AF XY:
AC XY:
332096
AN XY:
722810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.506 AC: 76741AN: 151606Hom.: 19917 Cov.: 30 AF XY: 0.508 AC XY: 37647AN XY: 74070
GnomAD4 genome
AF:
AC:
76741
AN:
151606
Hom.:
Cov.:
30
AF XY:
AC XY:
37647
AN XY:
74070
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2030
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SARDH-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at